Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TRD303 solution for postoperative analgesia after abdominal surgery
CTR20244973Phase 2Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TRD303 in postoperative pain (3 arms), sponsored by Beijing Tide Pharmaceutical Co., Ltd. Primary endpoint: AUC0-72h of pain intensity at rest. Started Jan 2025; status: completed.
02
Drugs
TRD303
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20244973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244973.